OKYO
OKYO Pharma Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.36
+3.03%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-72.6%
Return on equity
-42.7%
Return on assets
-74.6%
Return on invested capital
0.00x
Asset turnover
-$5.9M
Cash from operations
$0.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026